Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration
about
Protein- and diabetes-induced glomerular hyperfiltration: role of glucagon, vasopressin, and ureaAtrial natriuretic peptide signal pathway upregulated in stomach of streptozotocin-induced diabetic miceSpontaneously reduced blood pressure load in the rat streptozotocin-induced diabetes model: potential pathogenetic relevance.Optical control of a receptor-linked guanylyl cyclase using a photoswitchable peptidic hormone.Feasibility and impact of the measurement of extracellular fluid volume simultaneous with GFR by 125I-iothalamate.Pathophysiology of the diabetic kidney.Progressive increases in luminal glucose stimulate proximal sodium absorption in normal and diabetic rats.Microvascular haemodynamics in diabetes.Regulation of ANP clearance receptors by EGF in mesangial cells from NOD mice.Atrial natriuretic peptide inhibits cell cycle activity of embryonic cardiac progenitor cells via its NPRA receptor signaling axis.Role of nitric oxide in the pathogenesis of diabetic nephropathy in streptozotocin-induced diabetic ratsLong-term treatment with atrial natriuretic peptide inhibits ATP production and insulin secretion in rat pancreatic islets.Brain natriuretic peptide increases urinary albumin and alpha-1 microglobulin excretion in Type 1 diabetes mellitus.Canagliflozin Slows Progression of Renal Function Decline Independently of Glycemic Effects.Preventive effects of North American ginseng (Panax quinquefolius) on diabetic retinopathy and cardiomyopathy.The Canagliflozin and Renal Endpoints in Diabetes with Established Nephropathy Clinical Evaluation (CREDENCE) Study Rationale, Design, and Baseline Characteristics.Combined neprilysin and RAS inhibition for the failing heart: straining the kidney to help the heart?
P2860
Q28085593-7F7B854C-FEE2-40D5-A74B-2DD18DA4E338Q33564976-7DCFB626-81D0-459C-AA6E-9C43C10E7D5DQ35629267-2F4A190F-2802-42E6-A16A-B3240D66CEF6Q36408637-BBC21822-6643-4948-A5FA-F15D725D6E10Q36843457-273397B1-3E36-4FB9-942C-78573B95B71FQ38111707-9A87B0C3-5FCB-43BC-B400-B11DF8CCB17AQ40347684-A3EE6FB6-9639-4B44-B283-1F8222660E38Q40442549-2D99D423-0F2C-4496-8C47-2CC3515605EBQ40791983-C0D53375-F0BC-441A-9795-B3275154CE52Q41511312-FECCEF45-5FFA-4E33-86C4-C2D34B3773B0Q42431428-5EAB97CC-B4BC-4A0A-8BD4-8D7D8915E30AQ42478590-54DB04EB-548E-4C8F-A50A-31BB8BC97EE2Q43923288-D4EDC694-B916-4A2C-B3A0-B77A4E95F632Q47134445-575243D4-F1FB-4855-A6A2-160C9D2BAF06Q47795728-917AC6D8-52B2-4F57-90BE-84066076AF2FQ49658111-830F8506-21EF-4243-ADA9-06EEFE1ECFB7Q50851996-26A2794A-B505-40AA-8E07-E33204630633
P2860
Elevated plasma atrial natriuretic peptide levels in diabetic rats. Potential mediator of hyperfiltration
description
1987 nî lūn-bûn
@nan
1987年の論文
@ja
1987年論文
@yue
1987年論文
@zh-hant
1987年論文
@zh-hk
1987年論文
@zh-mo
1987年論文
@zh-tw
1987年论文
@wuu
1987年论文
@zh
1987年论文
@zh-cn
name
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@ast
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@en
type
label
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@ast
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@en
prefLabel
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@ast
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@en
P2093
P2860
P356
P1476
Elevated plasma atrial natriur ...... al mediator of hyperfiltration
@en
P2093
B J Ballermann
B M Brenner
F V Ortola
R E Mendez
S Anderson
P2860
P304
P356
10.1172/JCI113120
P407
P577
1987-09-01T00:00:00Z